Metraipolis › archive › dc_effec53cb2e2

Islet function impairment outcomes of immune checkpoint inhibitors in cancer patients: a systematic review and meta-analysis — Europe PMC PMID:41939914

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41939914
DOI: 10.3389/fimmu.2026.1669492
License (as archived): solo-consultazione
Archived: 2026-11-04T05:02:31.380Z
SHA-256 of the archived text: 96b7c582b3bdb79af0ab00f0eb310d1bad276e01aff856d70ddcaadcb01aca0e
Stable URL of this page: https://metraipolis.com/documento/dc_effec53cb2e2

How to cite

Islet function impairment outcomes of immune checkpoint inhibitors in cancer patients: a systematic review and meta-analysis — Europe PMC PMID:41939914 — Europe PMC (en), https://europepmc.org/article/MED/41939914 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_effec53cb2e2 (Metraipolis archive dc_effec53cb2e2, sha256 96b7c582b3bdb79af0ab00f0eb310d1bad276e01aff856d70ddcaadcb01aca0e)

BibTeX

@misc{dceffec53cb2e2,
  title = {Islet function impairment outcomes of immune checkpoint inhibitors in cancer patients: a systematic review and meta-analysis — Europe PMC PMID:41939914},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41939914},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_effec53cb2e2; sha256 96b7c582b3bdb79af0ab00f0eb310d1bad276e01aff856d70ddcaadcb01aca0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41939914. Agents can read the archived copy with the MCP tool read_document.